Ingemar Ernberg mainly investigates Epstein–Barr virus, Virology, Virus, Molecular biology and Antigen. His studies deal with areas such as Carcinoma and Lymphoma as well as Epstein–Barr virus. His research in Virology intersects with topics in Peptide sequence and Transplantation.
Ingemar Ernberg works on Virus which deals in particular with Herpesviridae. His Molecular biology research includes themes of Cell culture, Epstein–Barr virus latent membrane protein 1 and Carcinogenesis, Gene expression, Gene. Ingemar Ernberg has included themes like Antibody, Raji cell and Burkitt's lymphoma in his Antigen study.
His primary areas of study are Epstein–Barr virus, Virology, Virus, Molecular biology and Immunology. His Epstein–Barr virus study combines topics from a wide range of disciplines, such as Methylation, Antigen, Herpesviridae, Lymphoma and Antibody. His Virology research is multidisciplinary, incorporating perspectives in Cell culture and DNA synthesis.
His work on Virus is being expanded to include thematically relevant topics such as Leukemia. His Molecular biology research integrates issues from Gene expression, Gene, DNA methylation, DNA and Immunofluorescence. While the research belongs to areas of Immunology, Ingemar Ernberg spends his time largely on the problem of Internal medicine, intersecting his research to questions surrounding Oncology.
Odds ratio, Case-control study, Epstein–Barr virus, Internal medicine and Immunology are his primary areas of study. His research integrates issues of Absolute risk reduction, Confidence interval and Environmental health in his study of Odds ratio. His Epstein–Barr virus study is associated with Virology.
His research on Internal medicine also deals with topics like
The scientist’s investigation covers issues in Odds ratio, Cancer, Demography, Case-control study and Confidence interval. His Cancer study combines topics from a wide range of disciplines, such as Nursing, Translational research and MEDLINE. His MEDLINE study integrates concerns from other disciplines, such as Medical physics, Precision oncology and Tumor board.
His Case-control study study combines topics in areas such as Logistic regression, Oral hygiene, Dentistry and Confounding. His work often combines Absolute risk reduction and Nasopharyngeal neoplasm studies. His Carcinoma research is included under the broader classification of Internal medicine.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Gene expression perturbation in vitro--a growing case for three-dimensional (3D) culture systems.
Anna Birgersdotter;Rickard Sandberg;Ingemar Ernberg.
Seminars in Cancer Biology (2005)
Expression of Epstein-Barr virus-encoded proteins in nasopharyngeal carcinoma.
Robin Fåhraeus;Hu Li Fu;Ingemar Ernberg;Jurgen Finke.
International Journal of Cancer (1988)
Cancer attractors: a systems view of tumors from a gene network dynamics and developmental perspective
Sui Huang;Ingemar Ernberg;Stuart Kauffman.
Seminars in Cell & Developmental Biology (2009)
Epstein-Barr virus (EBV) load in bone marrow transplant recipients at risk to develop posttransplant lymphoproliferative disease: prophylactic infusion of EBV-specific cytotoxic T cells.
Åsa Gustafsson;Victor Levitsky;Jie Zhi Zou;Teresa Frisan.
Isolation and sequencing of the Epstein-Barr virus BNLF-1 gene (LMP1) from a Chinese nasopharyngeal carcinoma.
Li-Fu Hu;Eugene R. Zabarovsky;Fu Chen;Shi-Long Cao.
Journal of General Virology (1991)
EBV gene expression in an NPC-related tumour.
M.M. Hitt;M.J. Allday;T. Hara;L. Karran.
The EMBO Journal (1989)
Systems medicine and integrated care to combat chronic noncommunicable diseases
Jean Bousquet;Josep M. Anto;Peter J. Sterk;Ian M. Adcock.
Research Papers in Economics (2011)
Eradication of Epstein-Barr virus by allogeneic bone marrow transplantation: implications for sites of viral latency
J. W. Gratama;M. A. P. Oosterveer;F. E. Zwaan;J. Lepoutre.
Proceedings of the National Academy of Sciences of the United States of America (1988)
Antibody responses to Epstein-Barr virus-determined nuclear antigen (EBNA)-1 and EBNA-2 in acute and chronic Epstein-Barr virus infection
Werner Henle;Gertrude Henle;Jan Andersson;Ingemar Ernberg.
Proceedings of the National Academy of Sciences of the United States of America (1987)
Capturing whole-genome characteristics in short sequences using a naïve Bayesian classifier.
Rickard Sandberg;Gösta Winberg;Carl-Ivar Bränden;Alexander Kaske.
Genome Research (2001)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: